ICD-10-CM Billable Code

B60.8

Other specified protozoal diseases

Clinical Classification Guidelines

Inclusion Terms

  • Microsporidiosis

Medical Intelligence & Overview

Microsporidiosis is a parasitic infection caused by microsporidia, a group of tiny, spore-forming microorganisms. These parasites can infect various tissues in the human body, leading to a range of health issues. The condition is classified under ICD-10 code B60.8 as 'Other specified protozoal diseases,' indicating that it involves protozoan pathogens not categorized under more common protozoal infections. Microsporidiosis is considered an opportunistic infection, primarily affecting individuals with weakened immune systems, such as those with HIV/AIDS or undergoing immunosuppressive therapy. Though once considered rare, increased awareness and improved diagnostic methods have highlighted its significance in clinical settings.

Causes & Symptoms

Clinical Causes: Infection with microsporidia spores through contaminated water, food, or environmental exposure Transmission via contact with infected individuals or animals Inhalation of spores leading to respiratory infections Transmission through intravenous drug use or blood transfusions in certain cases Reactivation of latent infections in immunocompromised individuals

Key Symptoms: Persistent diarrhea, especially in immunocompromised individuals Weight loss due to malabsorption and ongoing illness Abdominal pain and cramping Fever and malaise Respiratory symptoms such as cough or shortness of breath when lung involvement occurs Ocular symptoms like blurred vision or eye discomfort if the eyes are affected Muscle pain or weakness

Diagnostic & Treatment

Diagnosis Path: Diagnosing microsporidiosis involves a combination of clinical assessment and laboratory tests. Key diagnostic approaches include: - Microscopic examination of tissue biopsies or body fluids using special stains that highlight microsporidia spores - Electron microscopy for detailed visualization of spores - Molecular techniques such as PCR (Polymerase Chain Reaction) to detect microsporidia DNA - Serological tests, although these are less commonly used Accurate diagnosis often requires demonstrating the presence of microsporidia in tissue or bodily fluids, emphasizing the importance of specialized laboratory support in confirmed cases.

Treatment Protocols: Management of microsporidiosis typically involves antiparasitic medications aimed at eliminating the infection. The choice of treatment depends on the specific microsporidia species involved and the site of infection. Common treatments include: - Albendazole, especially effective against certain microsporidia species affecting the intestines and other tissues - Fumagillin, sometimes used for ocular microsporidiosis - Supportive care to manage symptoms such as hydration for diarrhea and nutritional support - Reversal or reduction of immunosuppression when feasible to help the immune system clear the infection Treatment duration varies, and close medical supervision is essential to monitor response and potential side effects.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is B60.8 a billable ICD-10 code?
Yes, B60.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report B60.8?
Clinical documentation must specify the nature of Other specified protozoal diseases and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

protozoal diseases